Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peripheral insulin sensitivity pathway refers to the molecular and cellular mechanisms by which insulin regulates glucose uptake and metabolism in peripheral tissues, primarily skeletal muscle, adipose tissue, and liver. This pathway involves a cascade of events starting with insulin binding to its receptor, leading to downstream signaling through IRS proteins, PI3K, Akt, and ultimately, GLUT4 translocation to the cell membrane for glucose uptake. Impairment of this pathway contributes to peripheral insulin resistance, a hallmark of metabolic disorders like type 2 diabetes and obesity.
Various, depending on the specific target within the pathway. Examples: Metformin enhances insulin sensitivity; Thiazolidinediones activate PPARγ, improving insulin sensitivity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral Insulin Sensitivity Pathway.